Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 2.77 EUR -3.82% Market Closed
Market Cap: 29.8m EUR
Have any thoughts about
Biosynex SA?
Write Note

Biosynex SA
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biosynex SA
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Biosynex SA
PAR:ALBIO
PP&E Net
€15.7m
CAGR 3-Years
45%
CAGR 5-Years
81%
CAGR 10-Years
44%
Edap Tms SA
NASDAQ:EDAP
PP&E Net
€8.2m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
17%
Biomerieux SA
PAR:BIM
PP&E Net
€1.6B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
14%
Carmat SA
PAR:ALCAR
PP&E Net
€10.1m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
30%
Visiomed Group SA
PAR:ALVMG
PP&E Net
€5.2m
CAGR 3-Years
158%
CAGR 5-Years
37%
CAGR 10-Years
26%
Amplitude Surgical SA
PAR:AMPLI
PP&E Net
€41.5m
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Biosynex SA
Glance View

Market Cap
28.9m EUR
Industry
Health Care

Biosynex SA engages in the development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. The company is headquartered in Illkirch-Graffenstaden, Grand Est. The company went IPO on 2011-03-21. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). The company operates through Fumouze Diagnostics and SR2B.

ALBIO Intrinsic Value
7.73 EUR
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Biosynex SA's PP&E Net?
PP&E Net
15.7m EUR

Based on the financial report for Jun 30, 2024, Biosynex SA's PP&E Net amounts to 15.7m EUR.

What is Biosynex SA's PP&E Net growth rate?
PP&E Net CAGR 10Y
44%

Over the last year, the PP&E Net growth was -9%. The average annual PP&E Net growth rates for Biosynex SA have been 45% over the past three years , 81% over the past five years , and 44% over the past ten years .

Back to Top